Prosecution Insights
Last updated: October 26, 2026

Regina M Deberry, USPTO Patent Examiner

Listed by the USPTO as DEBERRY, REGINA M

Tech Center 1600 • Art Units: 1647 1674 1677

This examiner grants 50% of resolved cases

Analysis

DEBERRY, REGINA M is a USPTO patent examiner in tech center 1600 and art unit 1647. The profile covers 604 resolved cases, with an allowance rate of 50.2%. The median time to allowance is 1238 days. Interview lift is 30.8%, associating interviews with a meaningful improvement in allowance results in the reported data.

The principal companies are Hoffmann-La Roche Inc., Arizona Board of Regents on Behalf of Arizona State University, and Genahead Bio Inc. The leading firms are FOLEY & LARDNER LLP, SUGHRUE MION, PLLC, and Clark+Elbing LLP - Genentech and Roche. Counsel may find interview preparation especially relevant when developing amendment and response strategy.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

50.2%
Allow Rate
-9.8% vs TC avg
643
Total Applications
+30.8%
Interview Lift
1238
Avg Prosecution Days
Based on 604 resolved cases, 2023–2026

Rejection Statute Breakdown

2.2%
§101 Eligibility
18.7%
§102 Novelty
28.8%
§103 Obviousness
37.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19542772 ANTI-INTERLEUKIN-11 ANTIBODIES AND METHODS OF USE THEREOF Non-Final OA Boehringer Ingelheim International GmbH
18629145 METHOD AND DEVICE FOR DETECTING SIGLEC12 Non-Final OA The Regents of the University of California
17782469 STANDARD SUBSTANCE FOR PSA QUANTIFICATION, PREPARATION METHOD THEREFOR, STANDARD SOLUTION FOR PSA QUANTIFICATION, AND PSA QUANTIFICATION METHOD Non-Final OA OTSUKA PHARMACEUTICAL CO., LTD.
18030983 COMPOSITIONS FOR TREATMENT ALOPECIA AREATA, BIOMARKERS FOR TREATMENT SUCCESS AND, METHODS OF USE THEREOF Non-Final OA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Regina M Deberry's allowance rate?

50.2% of resolved applications examined by Regina M Deberry were allowed (604 resolved cases), compared with 39.7% across Art Unit 1647 over the last five years.

Does an interview help with examiner Regina M Deberry?

This examiner's interview lift is +30.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Regina M Deberry take to allow a patent?

Applications allowed by Regina M Deberry took 1,238 days on average from filing to allowance.

Which art unit does examiner Regina M Deberry work in?

Regina M Deberry examines applications in Art Unit 1647 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month